Veradigm (NASDAQ:MDRX) Shares Up 4% – Should You Buy?

Shares of Veradigm Inc. (NASDAQ:MDRX – Get Free Report) shot up 4% on Friday. The company traded as high as $5.00 and last traded at $5.00. Approximately 1,572 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 124,846 shares. The stock had previously closed at $4.81.

Veradigm Stock Up 1.0%

The stock’s 50-day moving average price is $4.86 and its 200 day moving average price is $4.76. The company has a market cap of $611.50 million, a P/E ratio of 23.25 and a beta of 0.56.

Veradigm Company Profile

(Get Free Report)

Veradigm Inc is a healthcare technology company that develops software, data, and connectivity solutions for healthcare providers, payers, pharmaceutical and life sciences companies, and other organizations across the healthcare ecosystem. The company’s offerings are designed to support clinical workflows, improve patient engagement, facilitate information exchange, and help organizations use healthcare data more effectively.

Its products and services include electronic health record and practice-management software, revenue-cycle management tools, e-prescribing and patient-engagement solutions, and analytics and data services.

Featured Articles

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.